Physiologic Signals and Signatures With the Accuryn Monitoring System (The Accuryn Registry)
- Conditions
- Intraabdominal HypertensionCardiovascular SurgeryAbdominal Compartment SyndromeAcute Kidney Injury
- Interventions
- Device: Accuryn Monitoring System
- Registration Number
- NCT04585555
- Lead Sponsor
- Potrero Medical
- Brief Summary
The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using electronic medical records and data streams via the Accuryn Monitoring System.
- Detailed Description
The primary objective of the Accuryn Registry Study is to is to track and analyze changes in physiologic data streams using the Accuryn Monitoring System and correlate these changes to the occurrence of acute kidney injury (AKI) following cardiovascular surgery intervention(s).
The secondary objective is to determine the incidence of IAH and ACS in the cardiovascular surgery population and the correlation of these diagnoses to the diagnosis of AKI.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
- Adult (age ≥ 18).
- Monitored on the Accuryn® Monitoring System during hospital stay.
- Patient is undergoing cardiovascular surgical intervention(s).
- The patient is unsuitable for the study, in the opinion of the investigator. This may include vulnerable patient populations such as prisoners or those detained in a penal institution.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Accuryn Monitoring System Accuryn Monitoring System Observational only (no intervention). Patients undergoing cardiovascular surgical intervention(s) monitored with the Accuryn Monitoring System (per standard of care) during their hospital stay.
- Primary Outcome Measures
Name Time Method Intra-Abdominal Pressure (IAP) 30 days Intra-Abdominal Pressure (mmHg) trending while on a urinary catheter, as well as active measurements taken by clinician
Temperature (T) 30 days Temperature (degrees Celsius) trending during hospital stay
Abdominal Compartment Syndrome (ACS) 30 days Intra-abdominal pressure (IAP) above 20 mm Hg with new organ dysfunction or failure (timepoint and duration)
Urine Output (UO) 30 days High accuracy Urine Output (mL/hour) while on a urinary catheter, and estimated UO while not on a urinary catheter
Intraabdominal Hypertension (IAH) 30 days Intra-abdominal pressure (IAP) above 12 mm Hg (timepoint and duration)
Acute Kidney Injury (AKI) 30 days % of patients diagnosed with AKI, and hospitalization day of diagnosis. AKI diagnosed per KDIGO criteria (Stage 1 to 3)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Emory University Hospital
🇺🇸Atlanta, Georgia, United States